[{"edinetCode":"E00952","endDate":"2017\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":2361.0,"averageTemporaryStaff":1661.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":8019000.0,"sharesOwendPercent":0.394,"outstandingShares":null,"numberOfSubsidiary":15.0,"bps":3359.84,"equityRatio":0.487,"cashAndCashEquivalents":16207000000.0,"assets":109648000000.0,"currentAssets":60054000000.0,"fixedAsset":49593000000.0,"tangibleFixedAssets":28238000000.0,"intangibleFixedAssets":774000000.0,"investmentAndOtherAssets":20580000000.0,"liabilities":55731000000.0,"currentLiabilities":30664000000.0,"shorTermDept":13956000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":25066000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":19192000000.0,"netAsset":53916000000.0,"capitalStock":43544000000.0,"capital":2537000000.0,"capitalSurplus":2718000000.0,"accumulatedEarnings":53771000000.0,"treasuryStock":-15483000000.0,"valuationAndConversionAdjustments":9831000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":87181000000.0,"costOfSales":59854000000.0,"grossProfit":27326000000.0,"sgaExpenses":20265000000.0,"salaryAndBenefit":null,"depreciationAndSGA":210000000.0,"RDExpenses":2791000000.0,"operatingIncome":7061000000.0,"nonOperatingIncome":583000000.0,"nonOperatingExpenses":1155000000.0,"interestExpense":704000000.0,"ordinaryProfit":6489000000.0,"extraordinaryGain":322000000.0,"extraordinaryLoss":663000000.0,"incomeBeforeTax":6148000000.0,"incomeTaxes":1792000000.0,"netIncome":4356000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":4330000000.0,"comprehensiveIncome":3249000000.0,"eps":270.06,"dilutedEps":269.7,"dividendPerShare":null,"per":14.9,"roe":0.068,"cashFlowFromOperatingActivities":8126000000.0,"depreciationAndCashflowFromOperatingActivities":3496000000.0,"cashFlowFromInvestingActivities":-3080000000.0,"cashFlowFromFinancialActivities":-1881000000.0,"changesInCashAndCashEquivalents":2883000000.0,"列1":"asr","submitDate":"2017\/6\/27","stockCode":4526,"accountingYear":"第81期（自　平成28年４月１日　至　平成29年３月31日）","accountingYearStart":"2016\/4\/1","accountingYearEnd":"2017\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00952","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2537,"settlementDate":"2022\/3\/31","submitterName":"理研ビタミン株式会社","submitterNameEnglish":"Riken Vitamin Co., Ltd.","submitterNameKana":"リケンビタミンカブシキガイシャ","location":"千代田区三崎町二丁目９番１８号","industory":"食料品","corporateNumber":3010000000000.0},{"edinetCode":"E00952","endDate":"2018\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":2306.0,"averageTemporaryStaff":1923.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":6985000.0,"sharesOwendPercent":0.4243,"outstandingShares":null,"numberOfSubsidiary":14.0,"bps":3638.86,"equityRatio":0.532,"cashAndCashEquivalents":14488000000.0,"assets":112192000000.0,"currentAssets":60436000000.0,"fixedAsset":51756000000.0,"tangibleFixedAssets":28764000000.0,"intangibleFixedAssets":701000000.0,"investmentAndOtherAssets":22290000000.0,"liabilities":52083000000.0,"currentLiabilities":28697000000.0,"shorTermDept":9462000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":23386000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":17000000000.0,"netAsset":60109000000.0,"capitalStock":50130000000.0,"capital":2537000000.0,"capitalSurplus":3047000000.0,"accumulatedEarnings":58343000000.0,"treasuryStock":-13797000000.0,"valuationAndConversionAdjustments":9514000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":89515000000.0,"costOfSales":62427000000.0,"grossProfit":27088000000.0,"sgaExpenses":20823000000.0,"salaryAndBenefit":null,"depreciationAndSGA":225000000.0,"RDExpenses":2895000000.0,"operatingIncome":6264000000.0,"nonOperatingIncome":592000000.0,"nonOperatingExpenses":1430000000.0,"interestExpense":739000000.0,"ordinaryProfit":5427000000.0,"extraordinaryGain":3206000000.0,"extraordinaryLoss":356000000.0,"incomeBeforeTax":8277000000.0,"incomeTaxes":2654000000.0,"netIncome":5622000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":5640000000.0,"comprehensiveIncome":5341000000.0,"eps":345.3,"dilutedEps":345.21,"dividendPerShare":null,"per":11.9,"roe":0.1,"cashFlowFromOperatingActivities":5753000000.0,"depreciationAndCashflowFromOperatingActivities":3639000000.0,"cashFlowFromInvestingActivities":-1617000000.0,"cashFlowFromFinancialActivities":-5869000000.0,"changesInCashAndCashEquivalents":-1718000000.0,"列1":"asr","submitDate":"2018\/6\/26","stockCode":4526,"accountingYear":"第82期（自　平成29年４月１日　至　平成30年３月31日）","accountingYearStart":"2017\/4\/1","accountingYearEnd":"2018\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00952","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2537,"settlementDate":"2022\/3\/31","submitterName":"理研ビタミン株式会社","submitterNameEnglish":"Riken Vitamin Co., Ltd.","submitterNameKana":"リケンビタミンカブシキガイシャ","location":"千代田区三崎町二丁目９番１８号","industory":"食料品","corporateNumber":3010000000000.0},{"edinetCode":"E00952","endDate":"2019\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":2285.0,"averageTemporaryStaff":1769.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":6527000.0,"sharesOwendPercent":0.3955,"outstandingShares":null,"numberOfSubsidiary":14.0,"bps":3730.22,"equityRatio":0.549,"cashAndCashEquivalents":15157000000.0,"assets":111392000000.0,"currentAssets":59018000000.0,"fixedAsset":52373000000.0,"tangibleFixedAssets":27867000000.0,"intangibleFixedAssets":656000000.0,"investmentAndOtherAssets":23849000000.0,"liabilities":49767000000.0,"currentLiabilities":28827000000.0,"shorTermDept":9753000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":20940000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":15243000000.0,"netAsset":61624000000.0,"capitalStock":52826000000.0,"capital":2537000000.0,"capitalSurplus":3079000000.0,"accumulatedEarnings":61040000000.0,"treasuryStock":-13831000000.0,"valuationAndConversionAdjustments":8315000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":89888000000.0,"costOfSales":63510000000.0,"grossProfit":26377000000.0,"sgaExpenses":21324000000.0,"salaryAndBenefit":null,"depreciationAndSGA":276000000.0,"RDExpenses":2872000000.0,"operatingIncome":5052000000.0,"nonOperatingIncome":799000000.0,"nonOperatingExpenses":990000000.0,"interestExpense":756000000.0,"ordinaryProfit":4860000000.0,"extraordinaryGain":1314000000.0,"extraordinaryLoss":130000000.0,"incomeBeforeTax":6044000000.0,"incomeTaxes":2070000000.0,"netIncome":3973000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":3949000000.0,"comprehensiveIncome":2768000000.0,"eps":240.94,"dilutedEps":null,"dividendPerShare":null,"per":14.6,"roe":0.065,"cashFlowFromOperatingActivities":6689000000.0,"depreciationAndCashflowFromOperatingActivities":3915000000.0,"cashFlowFromInvestingActivities":-3388000000.0,"cashFlowFromFinancialActivities":-2490000000.0,"changesInCashAndCashEquivalents":669000000.0,"列1":"asr","submitDate":"2019\/6\/25","stockCode":4526,"accountingYear":"第83期（自　2018年４月１日　至　2019年３月31日）","accountingYearStart":"2018\/4\/1","accountingYearEnd":"2019\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00952","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2537,"settlementDate":"2022\/3\/31","submitterName":"理研ビタミン株式会社","submitterNameEnglish":"Riken Vitamin Co., Ltd.","submitterNameKana":"リケンビタミンカブシキガイシャ","location":"千代田区三崎町二丁目９番１８号","industory":"食料品","corporateNumber":3010000000000.0},{"edinetCode":"E00952","endDate":"2019\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.562,"cashAndCashEquivalents":null,"assets":108249000000.0,"currentAssets":57859000000.0,"fixedAsset":50389000000.0,"tangibleFixedAssets":27734000000.0,"intangibleFixedAssets":676000000.0,"investmentAndOtherAssets":21978000000.0,"liabilities":46979000000.0,"currentLiabilities":26565000000.0,"shorTermDept":9448000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":20414000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":15243000000.0,"netAsset":61269000000.0,"capitalStock":53163000000.0,"capital":2537000000.0,"capitalSurplus":3079000000.0,"accumulatedEarnings":61371000000.0,"treasuryStock":-13825000000.0,"valuationAndConversionAdjustments":7646000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":22864000000.0,"costOfSales":15913000000.0,"grossProfit":6950000000.0,"sgaExpenses":5310000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":1640000000.0,"nonOperatingIncome":449000000.0,"nonOperatingExpenses":514000000.0,"interestExpense":183000000.0,"ordinaryProfit":1575000000.0,"extraordinaryGain":20000000.0,"extraordinaryLoss":58000000.0,"incomeBeforeTax":1537000000.0,"incomeTaxes":499000000.0,"netIncome":1038000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":1040000000.0,"comprehensiveIncome":348000000.0,"eps":63.45,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2019\/8\/9","stockCode":4526,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00952","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2537,"settlementDate":"2022\/3\/31","submitterName":"理研ビタミン株式会社","submitterNameEnglish":"Riken Vitamin Co., Ltd.","submitterNameKana":"リケンビタミンカブシキガイシャ","location":"千代田区三崎町二丁目９番１８号","industory":"食料品","corporateNumber":3010000000000.0},{"edinetCode":"E00952","endDate":"2019\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":6587000.0,"sharesOwendPercent":0.3992,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.576,"cashAndCashEquivalents":12921000000.0,"assets":107492000000.0,"currentAssets":55993000000.0,"fixedAsset":51498000000.0,"tangibleFixedAssets":28367000000.0,"intangibleFixedAssets":649000000.0,"investmentAndOtherAssets":22481000000.0,"liabilities":45111000000.0,"currentLiabilities":25698000000.0,"shorTermDept":9173000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":19413000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":14216000000.0,"netAsset":62380000000.0,"capitalStock":54236000000.0,"capital":2537000000.0,"capitalSurplus":3079000000.0,"accumulatedEarnings":62436000000.0,"treasuryStock":-13817000000.0,"valuationAndConversionAdjustments":7679000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":48336000000.0,"costOfSales":34377000000.0,"grossProfit":13959000000.0,"sgaExpenses":10584000000.0,"salaryAndBenefit":null,"depreciationAndSGA":145000000.0,"RDExpenses":1538000000.0,"operatingIncome":3375000000.0,"nonOperatingIncome":626000000.0,"nonOperatingExpenses":922000000.0,"interestExpense":365000000.0,"ordinaryProfit":3078000000.0,"extraordinaryGain":20000000.0,"extraordinaryLoss":79000000.0,"incomeBeforeTax":3019000000.0,"incomeTaxes":903000000.0,"netIncome":2115000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":2105000000.0,"comprehensiveIncome":1454000000.0,"eps":128.42,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":1874000000.0,"depreciationAndCashflowFromOperatingActivities":1948000000.0,"cashFlowFromInvestingActivities":-1926000000.0,"cashFlowFromFinancialActivities":-2121000000.0,"changesInCashAndCashEquivalents":-2236000000.0,"列1":"q2r","submitDate":"2019\/11\/14","stockCode":4526,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00952","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2537,"settlementDate":"2022\/3\/31","submitterName":"理研ビタミン株式会社","submitterNameEnglish":"Riken Vitamin Co., Ltd.","submitterNameKana":"リケンビタミンカブシキガイシャ","location":"千代田区三崎町二丁目９番１８号","industory":"食料品","corporateNumber":3010000000000.0},{"edinetCode":"E00952","endDate":"2019\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.582,"cashAndCashEquivalents":null,"assets":109639000000.0,"currentAssets":57352000000.0,"fixedAsset":52286000000.0,"tangibleFixedAssets":27756000000.0,"intangibleFixedAssets":629000000.0,"investmentAndOtherAssets":23900000000.0,"liabilities":45311000000.0,"currentLiabilities":25256000000.0,"shorTermDept":8079000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":20054000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":14506000000.0,"netAsset":64327000000.0,"capitalStock":55620000000.0,"capital":2537000000.0,"capitalSurplus":3079000000.0,"accumulatedEarnings":63812000000.0,"treasuryStock":-13809000000.0,"valuationAndConversionAdjustments":8215000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":72557000000.0,"costOfSales":51055000000.0,"grossProfit":21501000000.0,"sgaExpenses":15821000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":5680000000.0,"nonOperatingIncome":898000000.0,"nonOperatingExpenses":916000000.0,"interestExpense":548000000.0,"ordinaryProfit":5662000000.0,"extraordinaryGain":221000000.0,"extraordinaryLoss":81000000.0,"incomeBeforeTax":5801000000.0,"incomeTaxes":1628000000.0,"netIncome":4173000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":4149000000.0,"comprehensiveIncome":4062000000.0,"eps":253.1,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2020\/2\/14","stockCode":4526,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00952","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2537,"settlementDate":"2022\/3\/31","submitterName":"理研ビタミン株式会社","submitterNameEnglish":"Riken Vitamin Co., Ltd.","submitterNameKana":"リケンビタミンカブシキガイシャ","location":"千代田区三崎町二丁目９番１８号","industory":"食料品","corporateNumber":3010000000000.0},{"edinetCode":"E00952","endDate":"2020\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":2274.0,"averageTemporaryStaff":1464.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":13.0,"bps":1490.68,"equityRatio":0.468,"cashAndCashEquivalents":13604000000.0,"assets":104452000000.0,"currentAssets":55115000000.0,"fixedAsset":49337000000.0,"tangibleFixedAssets":28003000000.0,"intangibleFixedAssets":667000000.0,"investmentAndOtherAssets":20666000000.0,"liabilities":55079000000.0,"currentLiabilities":36191000000.0,"shorTermDept":9276000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":18887000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":13870000000.0,"netAsset":49373000000.0,"capitalStock":42755000000.0,"capital":2537000000.0,"capitalSurplus":3079000000.0,"accumulatedEarnings":50947000000.0,"treasuryStock":-13809000000.0,"valuationAndConversionAdjustments":6127000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":82974000000.0,"costOfSales":55515000000.0,"grossProfit":27458000000.0,"sgaExpenses":21069000000.0,"salaryAndBenefit":null,"depreciationAndSGA":320000000.0,"RDExpenses":3089000000.0,"operatingIncome":6389000000.0,"nonOperatingIncome":928000000.0,"nonOperatingExpenses":1190000000.0,"interestExpense":727000000.0,"ordinaryProfit":6127000000.0,"extraordinaryGain":224000000.0,"extraordinaryLoss":12249000000.0,"incomeBeforeTax":-5897000000.0,"incomeTaxes":1904000000.0,"netIncome":-7802000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-7851000000.0,"comprehensiveIncome":-10054000000.0,"eps":-239.48,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":5850000000.0,"depreciationAndCashflowFromOperatingActivities":4072000000.0,"cashFlowFromInvestingActivities":-4282000000.0,"cashFlowFromFinancialActivities":-3051000000.0,"changesInCashAndCashEquivalents":-1553000000.0,"列1":"asr","submitDate":"2020\/9\/30","stockCode":4526,"accountingYear":"第84期（自　2019年４月１日　至　2020年３月31日）","accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00952","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2537,"settlementDate":"2022\/3\/31","submitterName":"理研ビタミン株式会社","submitterNameEnglish":"Riken Vitamin Co., Ltd.","submitterNameKana":"リケンビタミンカブシキガイシャ","location":"千代田区三崎町二丁目９番１８号","industory":"食料品","corporateNumber":3010000000000.0},{"edinetCode":"E00952","endDate":"2020\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.443,"cashAndCashEquivalents":null,"assets":100879000000.0,"currentAssets":51073000000.0,"fixedAsset":49805000000.0,"tangibleFixedAssets":27647000000.0,"intangibleFixedAssets":663000000.0,"investmentAndOtherAssets":21494000000.0,"liabilities":55669000000.0,"currentLiabilities":37032000000.0,"shorTermDept":9926000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":18637000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":13596000000.0,"netAsset":45209000000.0,"capitalStock":37494000000.0,"capital":2537000000.0,"capitalSurplus":3079000000.0,"accumulatedEarnings":45686000000.0,"treasuryStock":-13809000000.0,"valuationAndConversionAdjustments":7220000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":18457000000.0,"costOfSales":14189000000.0,"grossProfit":4268000000.0,"sgaExpenses":4990000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":-722000000.0,"nonOperatingIncome":352000000.0,"nonOperatingExpenses":252000000.0,"interestExpense":169000000.0,"ordinaryProfit":-622000000.0,"extraordinaryGain":21000000.0,"extraordinaryLoss":917000000.0,"incomeBeforeTax":-1518000000.0,"incomeTaxes":332000000.0,"netIncome":-1850000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-1855000000.0,"comprehensiveIncome":-861000000.0,"eps":-56.58,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2020\/10\/28","stockCode":4526,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00952","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2537,"settlementDate":"2022\/3\/31","submitterName":"理研ビタミン株式会社","submitterNameEnglish":"Riken Vitamin Co., Ltd.","submitterNameKana":"リケンビタミンカブシキガイシャ","location":"千代田区三崎町二丁目９番１８号","industory":"食料品","corporateNumber":3010000000000.0},{"edinetCode":"E00952","endDate":"2020\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":13259000.0,"sharesOwendPercent":0.4018,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.444,"cashAndCashEquivalents":12684000000.0,"assets":100689000000.0,"currentAssets":49179000000.0,"fixedAsset":51510000000.0,"tangibleFixedAssets":27907000000.0,"intangibleFixedAssets":673000000.0,"investmentAndOtherAssets":22929000000.0,"liabilities":55469000000.0,"currentLiabilities":49349000000.0,"shorTermDept":22530000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":6119000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":569000000.0,"netAsset":45219000000.0,"capitalStock":36496000000.0,"capital":2537000000.0,"capitalSurplus":3079000000.0,"accumulatedEarnings":44683000000.0,"treasuryStock":-13803000000.0,"valuationAndConversionAdjustments":8229000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":37960000000.0,"costOfSales":28202000000.0,"grossProfit":9757000000.0,"sgaExpenses":10253000000.0,"salaryAndBenefit":null,"depreciationAndSGA":119000000.0,"RDExpenses":1513000000.0,"operatingIncome":-495000000.0,"nonOperatingIncome":404000000.0,"nonOperatingExpenses":470000000.0,"interestExpense":362000000.0,"ordinaryProfit":-561000000.0,"extraordinaryGain":50000000.0,"extraordinaryLoss":1770000000.0,"incomeBeforeTax":-2281000000.0,"incomeTaxes":569000000.0,"netIncome":-2851000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-2858000000.0,"comprehensiveIncome":-847000000.0,"eps":-87.18,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":2164000000.0,"depreciationAndCashflowFromOperatingActivities":1993000000.0,"cashFlowFromInvestingActivities":-2356000000.0,"cashFlowFromFinancialActivities":-643000000.0,"changesInCashAndCashEquivalents":-920000000.0,"列1":"q2r","submitDate":"2020\/11\/16","stockCode":4526,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00952","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2537,"settlementDate":"2022\/3\/31","submitterName":"理研ビタミン株式会社","submitterNameEnglish":"Riken Vitamin Co., Ltd.","submitterNameKana":"リケンビタミンカブシキガイシャ","location":"千代田区三崎町二丁目９番１８号","industory":"食料品","corporateNumber":3010000000000.0},{"edinetCode":"E00952","endDate":"2020\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.435,"cashAndCashEquivalents":null,"assets":104329000000.0,"currentAssets":52264000000.0,"fixedAsset":52065000000.0,"tangibleFixedAssets":27865000000.0,"intangibleFixedAssets":674000000.0,"investmentAndOtherAssets":23525000000.0,"liabilities":58451000000.0,"currentLiabilities":52198000000.0,"shorTermDept":22468000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":6252000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":451000000.0,"netAsset":45878000000.0,"capitalStock":36665000000.0,"capital":2537000000.0,"capitalSurplus":3079000000.0,"accumulatedEarnings":44851000000.0,"treasuryStock":-13804000000.0,"valuationAndConversionAdjustments":8710000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":59105000000.0,"costOfSales":42636000000.0,"grossProfit":16468000000.0,"sgaExpenses":15718000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":749000000.0,"nonOperatingIncome":717000000.0,"nonOperatingExpenses":599000000.0,"interestExpense":531000000.0,"ordinaryProfit":868000000.0,"extraordinaryGain":150000000.0,"extraordinaryLoss":2038000000.0,"incomeBeforeTax":-1018000000.0,"incomeTaxes":965000000.0,"netIncome":-1983000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-1997000000.0,"comprehensiveIncome":504000000.0,"eps":-60.91,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2021\/2\/15","stockCode":4526,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00952","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2537,"settlementDate":"2022\/3\/31","submitterName":"理研ビタミン株式会社","submitterNameEnglish":"Riken Vitamin Co., Ltd.","submitterNameKana":"リケンビタミンカブシキガイシャ","location":"千代田区三崎町二丁目９番１８号","industory":"食料品","corporateNumber":3010000000000.0},{"edinetCode":"E00952","endDate":"2021\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":2248.0,"averageTemporaryStaff":862.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":12380000.0,"sharesOwendPercent":0.3752,"outstandingShares":null,"numberOfSubsidiary":13.0,"bps":1407.47,"equityRatio":0.433,"cashAndCashEquivalents":18655000000.0,"assets":106535000000.0,"currentAssets":53326000000.0,"fixedAsset":53209000000.0,"tangibleFixedAssets":27861000000.0,"intangibleFixedAssets":681000000.0,"investmentAndOtherAssets":24667000000.0,"liabilities":59861000000.0,"currentLiabilities":52812000000.0,"shorTermDept":23920000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":7048000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":451000000.0,"netAsset":46674000000.0,"capitalStock":37043000000.0,"capital":2537000000.0,"capitalSurplus":3079000000.0,"accumulatedEarnings":45230000000.0,"treasuryStock":-13804000000.0,"valuationAndConversionAdjustments":9113000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":77722000000.0,"costOfSales":55711000000.0,"grossProfit":22010000000.0,"sgaExpenses":20643000000.0,"salaryAndBenefit":null,"depreciationAndSGA":237000000.0,"RDExpenses":3094000000.0,"operatingIncome":1367000000.0,"nonOperatingIncome":1262000000.0,"nonOperatingExpenses":976000000.0,"interestExpense":665000000.0,"ordinaryProfit":1652000000.0,"extraordinaryGain":426000000.0,"extraordinaryLoss":2086000000.0,"incomeBeforeTax":-7000000.0,"incomeTaxes":1603000000.0,"netIncome":-1610000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-1618000000.0,"comprehensiveIncome":1300000000.0,"eps":-49.36,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":7625000000.0,"depreciationAndCashflowFromOperatingActivities":3955000000.0,"cashFlowFromInvestingActivities":-2288000000.0,"cashFlowFromFinancialActivities":-180000000.0,"changesInCashAndCashEquivalents":5051000000.0,"列1":"asr","submitDate":"2021\/6\/22","stockCode":4526,"accountingYear":"第85期（自　2020年４月１日　至　2021年３月31日）","accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00952","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2537,"settlementDate":"2022\/3\/31","submitterName":"理研ビタミン株式会社","submitterNameEnglish":"Riken Vitamin Co., Ltd.","submitterNameKana":"リケンビタミンカブシキガイシャ","location":"千代田区三崎町二丁目９番１８号","industory":"食料品","corporateNumber":3010000000000.0},{"edinetCode":"E00952","endDate":"2021\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.626,"cashAndCashEquivalents":null,"assets":98030000000.0,"currentAssets":46977000000.0,"fixedAsset":51053000000.0,"tangibleFixedAssets":25476000000.0,"intangibleFixedAssets":653000000.0,"investmentAndOtherAssets":24923000000.0,"liabilities":36134000000.0,"currentLiabilities":31315000000.0,"shorTermDept":17661000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":4819000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":834000000.0,"netAsset":61896000000.0,"capitalStock":52025000000.0,"capital":2537000000.0,"capitalSurplus":3079000000.0,"accumulatedEarnings":60206000000.0,"treasuryStock":-13798000000.0,"valuationAndConversionAdjustments":9347000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":19500000000.0,"costOfSales":12986000000.0,"grossProfit":6513000000.0,"sgaExpenses":5504000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":1009000000.0,"nonOperatingIncome":317000000.0,"nonOperatingExpenses":252000000.0,"interestExpense":130000000.0,"ordinaryProfit":1074000000.0,"extraordinaryGain":12125000000.0,"extraordinaryLoss":156000000.0,"incomeBeforeTax":13043000000.0,"incomeTaxes":-2631000000.0,"netIncome":15674000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":15668000000.0,"comprehensiveIncome":15908000000.0,"eps":477.76,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2021\/8\/16","stockCode":4526,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00952","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2537,"settlementDate":"2022\/3\/31","submitterName":"理研ビタミン株式会社","submitterNameEnglish":"Riken Vitamin Co., Ltd.","submitterNameKana":"リケンビタミンカブシキガイシャ","location":"千代田区三崎町二丁目９番１８号","industory":"食料品","corporateNumber":3010000000000.0},{"edinetCode":"E00952","endDate":"2021\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":13488000.0,"sharesOwendPercent":0.4087,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.666,"cashAndCashEquivalents":7927000000.0,"assets":96681000000.0,"currentAssets":42942000000.0,"fixedAsset":53739000000.0,"tangibleFixedAssets":25917000000.0,"intangibleFixedAssets":683000000.0,"investmentAndOtherAssets":27139000000.0,"liabilities":31768000000.0,"currentLiabilities":17200000000.0,"shorTermDept":3571000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":14568000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":10657000000.0,"netAsset":64912000000.0,"capitalStock":53532000000.0,"capital":2537000000.0,"capitalSurplus":3079000000.0,"accumulatedEarnings":61700000000.0,"treasuryStock":-13785000000.0,"valuationAndConversionAdjustments":10849000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":38603000000.0,"costOfSales":25993000000.0,"grossProfit":12609000000.0,"sgaExpenses":10213000000.0,"salaryAndBenefit":null,"depreciationAndSGA":111000000.0,"RDExpenses":1494000000.0,"operatingIncome":2396000000.0,"nonOperatingIncome":450000000.0,"nonOperatingExpenses":328000000.0,"interestExpense":108000000.0,"ordinaryProfit":2518000000.0,"extraordinaryGain":12126000000.0,"extraordinaryLoss":175000000.0,"incomeBeforeTax":14469000000.0,"incomeTaxes":-2707000000.0,"netIncome":17177000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":17162000000.0,"comprehensiveIncome":18915000000.0,"eps":523.29,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":2478000000.0,"depreciationAndCashflowFromOperatingActivities":1838000000.0,"cashFlowFromInvestingActivities":-4003000000.0,"cashFlowFromFinancialActivities":-9645000000.0,"changesInCashAndCashEquivalents":-10727000000.0,"列1":"q2r","submitDate":"2021\/11\/11","stockCode":4526,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00952","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2537,"settlementDate":"2022\/3\/31","submitterName":"理研ビタミン株式会社","submitterNameEnglish":"Riken Vitamin Co., Ltd.","submitterNameKana":"リケンビタミンカブシキガイシャ","location":"千代田区三崎町二丁目９番１８号","industory":"食料品","corporateNumber":3010000000000.0},{"edinetCode":"E00952","endDate":"2021\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.635,"cashAndCashEquivalents":null,"assets":104189000000.0,"currentAssets":50612000000.0,"fixedAsset":53577000000.0,"tangibleFixedAssets":25749000000.0,"intangibleFixedAssets":679000000.0,"investmentAndOtherAssets":27148000000.0,"liabilities":37971000000.0,"currentLiabilities":19242000000.0,"shorTermDept":3136000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":18728000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":15060000000.0,"netAsset":66217000000.0,"capitalStock":55381000000.0,"capital":2537000000.0,"capitalSurplus":3072000000.0,"accumulatedEarnings":63556000000.0,"treasuryStock":-13785000000.0,"valuationAndConversionAdjustments":10818000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":59586000000.0,"costOfSales":40077000000.0,"grossProfit":19509000000.0,"sgaExpenses":14958000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":4550000000.0,"nonOperatingIncome":647000000.0,"nonOperatingExpenses":370000000.0,"interestExpense":143000000.0,"ordinaryProfit":4826000000.0,"extraordinaryGain":12468000000.0,"extraordinaryLoss":197000000.0,"incomeBeforeTax":17097000000.0,"incomeTaxes":-2630000000.0,"netIncome":19727000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":19712000000.0,"comprehensiveIncome":21434000000.0,"eps":600.98,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2022\/2\/10","stockCode":4526,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00952","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":2537,"settlementDate":"2022\/3\/31","submitterName":"理研ビタミン株式会社","submitterNameEnglish":"Riken Vitamin Co., Ltd.","submitterNameKana":"リケンビタミンカブシキガイシャ","location":"千代田区三崎町二丁目９番１８号","industory":"食料品","corporateNumber":3010000000000.0}]